Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease
The biochemical response to food intake must be precisely regulated. Because ingested sugars and fats can feed into many anabolic and catabolic pathways 1 , how our bodies handle nutrients depends on strategically positioned metabolic sensors that link the intrinsic nutritional value of a meal with...
Saved in:
Published in | Nature (London) Vol. 566; no. 7742; pp. 115 - 119 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.02.2019
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The biochemical response to food intake must be precisely regulated. Because ingested sugars and fats can feed into many anabolic and catabolic pathways
1
, how our bodies handle nutrients depends on strategically positioned metabolic sensors that link the intrinsic nutritional value of a meal with intermediary metabolism. Here we describe a subset of immune cells—integrin β7
+
natural gut intraepithelial T lymphocytes (natural IELs)—that is dispersed throughout the enterocyte layer of the small intestine and that modulates systemic metabolism. Integrin β7
−
mice that lack natural IELs are metabolically hyperactive and, when fed a high-fat and high-sugar diet, are resistant to obesity, hypercholesterolaemia, hypertension, diabetes and atherosclerosis. Furthermore, we show that protection from cardiovascular disease in the absence of natural IELs depends on the enteroendocrine-derived incretin GLP-1
2
, which is normally controlled by IELs through expression of the GLP-1 receptor. In this metabolic control system, IELs modulate enteroendocrine activity by acting as gatekeepers that limit the bioavailability of GLP-1. Although the function of IELs may prove advantageous when food is scarce, present-day overabundance of diets high in fat and sugar renders this metabolic checkpoint detrimental to health.
Integrin β7-dependent Glp1r
high
natural gut intraepithelial T lymphocytes that reside in the small intestine modulate dietary metabolism in mice by restricting the bioavailability of GLP-1. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Author Contributions. S.H. conceived project, designed, performed experiments, analyzed, interpreted data, and made figures; F.K. performed, analyzed, interpreted, and made figures; S.R., M.Nairz., A.A., C.M., D.S., A.M.F., C.C., J.E.M., C.V., W.C.P., Y.I., G.R.W., C.F-H. performed; R.W., P.L., C.F-H., D.J.D., M.N. provided intellectual input; R.W., C.F-H., D.J.D., M.N. provided materials; F.K.S. conceived, designed, interpreted, and wrote the manuscript. All edited the manuscript. The General Hospital Corporation has filed a U.S. patent application 62/771,668 with the U.S. Patent and Trademark office entitled “Targeting Intraepithelial Leukocytes for Treatment of Cardiometabolic Diseases”, which names F.K.S. and S.H. as inventors. |
ISSN: | 0028-0836 1476-4687 |
DOI: | 10.1038/s41586-018-0849-9 |